Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Tanaka

Showing results (21-30 of 284) with videos related to

Pageof 29
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 15, 2006
[Pharmacogenomics of cardiovascular pharmacology]Toshio Tanaka, Takehiko Oka, Hiroshi Iwao
FEBS Letters|March 23, 2011
Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseasesToshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto
Expert Review of Clinical Immunology|October 29, 2010
Tocilizumab for the treatment of rheumatoid arthritisToshio Tanaka, Atsushi Ogata, Masashi Narazaki
Animal Science Journal = Nihon Chikusan Gakkaiho|June 21, 2013
Relationship between stress levels of the antepartum cow and her newborn calfKatsuji Uetake, Kiyoshi Akiyama, Toshio Tanaka
Arthritis|November 8, 2012
Pathological role of interleukin-6 in psoriatic arthritisAtsushi Ogata, Atsushi Kumanogoh, Toshio Tanaka
International Journal of Cardiology|November 29, 2018
IL-6 blockade for myocardial infarctionAtsuhiko Iuchi, Hiroshi Harada, Toshio Tanaka
Expert Review of Clinical Immunology|May 12, 2017
The role and therapeutic targeting of IL-6 in rheumatoid arthritisMasashi Narazaki, Toshio Tanaka, Tadamitsu Kishimoto
Biochemical and Biophysical Research Communications|June 27, 2002
Secretory production of recombinant human C-reactive protein in Escherichia coli, capable of binding with phosphorylcholine, and its characterizationToshio Tanaka, Takekazu Horio, Yuhsi Matuo
The New England Journal of Medicine|August 18, 2006
Infliximab for rheumatoid arthritis in a patient with tuberculosisTomoshige Matsumoto, Toshio Tanaka, Ichiro Kawase
Immunotherapy|July 7, 2016
Immunotherapeutic implications of IL-6 blockade for cytokine stormToshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto
Pageof 29

Showing results (21-30 of 284) with videos related to

Sort By:
Pageof 29
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 15, 2006
[Pharmacogenomics of cardiovascular pharmacology]Toshio Tanaka, Takehiko Oka, Hiroshi Iwao
FEBS Letters|March 23, 2011
Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseasesToshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto
Expert Review of Clinical Immunology|October 29, 2010
Tocilizumab for the treatment of rheumatoid arthritisToshio Tanaka, Atsushi Ogata, Masashi Narazaki
Animal Science Journal = Nihon Chikusan Gakkaiho|June 21, 2013
Relationship between stress levels of the antepartum cow and her newborn calfKatsuji Uetake, Kiyoshi Akiyama, Toshio Tanaka
Arthritis|November 8, 2012
Pathological role of interleukin-6 in psoriatic arthritisAtsushi Ogata, Atsushi Kumanogoh, Toshio Tanaka
International Journal of Cardiology|November 29, 2018
IL-6 blockade for myocardial infarctionAtsuhiko Iuchi, Hiroshi Harada, Toshio Tanaka
Expert Review of Clinical Immunology|May 12, 2017
The role and therapeutic targeting of IL-6 in rheumatoid arthritisMasashi Narazaki, Toshio Tanaka, Tadamitsu Kishimoto
Biochemical and Biophysical Research Communications|June 27, 2002
Secretory production of recombinant human C-reactive protein in Escherichia coli, capable of binding with phosphorylcholine, and its characterizationToshio Tanaka, Takekazu Horio, Yuhsi Matuo
The New England Journal of Medicine|August 18, 2006
Infliximab for rheumatoid arthritis in a patient with tuberculosisTomoshige Matsumoto, Toshio Tanaka, Ichiro Kawase
Immunotherapy|July 7, 2016
Immunotherapeutic implications of IL-6 blockade for cytokine stormToshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto
Pageof 29